Mind Medicine (MindMed) (NASDAQ:MNMD) Research Coverage Started at Robert W. Baird

Robert W. Baird initiated coverage on shares of Mind Medicine (MindMed) (NASDAQ:MNMD – Free Report) in a research report released on Tuesday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $27.00 target price on the stock. MNMD has been the topic of a number of other reports. Royal Bank of Canada […]

Related Keywords

Canada ,Robertw Baird ,Leerink Partnrs ,Dan Karlin ,Robert Barrow ,Commonwealth Equity Services ,Regal Investment Advisors ,Medicine Mindmed Inc ,Royal Bank ,Mitchell Mcleod Pugh Williams Inc ,Bailard Inc ,Sageview Advisory Group ,Mind Medicine ,Free Report ,Marketbeat Ratings ,Stock Down ,Get Free Report ,View Advisory Group ,Investment Advisors ,Equity Services ,Mitchell Mcleod Pugh ,